We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
PolyPid announced that the first patient has been enrolled and randomized in a Phase 3 clinical trial called SHIELD (Surgical site Hospital acquired Infection prEvention with Local D-plex).
PolyPid has completed patient enrollment of 200 patients in its Phase 2 clinical trial evaluating D-PLEX100 for the prevention of post-abdominal surgery incisional site infections.